Article
|
Open Access
Featured
-
-
Article
| Open AccessFrequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma
- Kwan Yeung Wong
- , Qiumei Yao
- & Chor Sang Chim
-
Article
| Open AccessA compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma
- Domenica Ronchetti
- , Luca Agnelli
- & Antonino Neri
-
Article
| Open AccessEnumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma
- Nicholas A. Gherardin
- , Liyen Loh
- & Dale I. Godfrey
-
Article
| Open AccessIdentification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma
- Allison E. Drew
- , Oscar Moradei
- & Scott A. Ribich
-
Article
| Open AccessEvidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment
- Mayra Rachele Zarone
- , Gabriella Misso
- & Michele Caraglia
-
Article
| Open AccessMilder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events
- Eleni N. Tsakiri
- , Evangelos Terpos
- & Ioannis P. Trougakos
-
Article
| Open AccessAutomatic digital quantification of bone marrow myeloma volume in appendicular skeletons - clinical implications and prognostic significance
- Yuki Nishida
- , Shinya Kimura
- & Kosei Matsue
-
Article
| Open AccessLogic programming reveals alteration of key transcription factors in multiple myeloma
- Bertrand Miannay
- , Stéphane Minvielle
- & Carito Guziolowski
-
Article
| Open AccessSTAT3-induced long noncoding RNAs in multiple myeloma cells display different properties in cancer
- Stefanie Binder
- , Nadine Hösler
- & Friedemann Horn
-
Article
| Open AccessMTI-101 treatment inducing activation of Stim1 and TRPC1 expression is a determinant of response in multiple myeloma
- Michael F. Emmons
- , Nagaraju Anreddy
- & Lori A. Hazlehurst
-
Article
| Open AccessExtracellular matrix protein Reelin promotes myeloma progression by facilitating tumor cell proliferation and glycolysis
- Xiaodan Qin
- , Liang Lin
- & Qing Ge
-
Article
| Open AccessProteomic Characterization of the World Trade Center dust-activated mdig and c-myc signaling circuit linked to multiple myeloma
- Kai Wu
- , Lingzhi Li
- & Fei Chen
-
Article
| Open AccessIdentification of Doxorubicin as an Inhibitor of the IRE1α-XBP1 Axis of the Unfolded Protein Response
- Dadi Jiang
- , Connor Lynch
- & Albert C. Koong
-
Article
| Open AccessErythropoietin treatment in murine multiple myeloma: immune gain and bone loss
- Naamit Deshet-Unger
- , Sahar Hiram-Bab
- & Drorit Neumann
-
Article
| Open AccessThe proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells
- Xin Wang
- , Magdalena Mazurkiewicz
- & Padraig D’Arcy
-
Article
| Open AccessGeneration of a novel, multi-stage, progressive, and transplantable model of plasma cell neoplasms
- Takashi Asai
- , Megan A. Hatlen
- & Stephen D. Nimer
-
Article
| Open AccessRisk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries
- Tianhui Chen
- , Mahdi Fallah
- & Felipe Castro
-
Article
| Open AccessThe natural compound forskolin synergizes with dexamethasone to induce cell death in myeloma cells via BIM
- Virginie Follin-Arbelet
- , Kristine Misund
- & Heidi Kiil Blomhoff
-
Article
| Open AccessImplementation of genome-wide complex trait analysis to quantify the heritability in multiple myeloma
- Jonathan S. Mitchell
- , David C. Johnson
- & Richard S. Houlston
-
Article
| Open AccessMultiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway
- Yan Chen
- , Ruibin Huang
- & Guoan Chen
-
Article
| Open AccessMetabolic Profiling-based Data-mining for an Effective Chemical Combination to Induce Apoptosis of Cancer Cells
- Motofumi Kumazoe
- , Yoshinori Fujimura
- & Hirofumi Tachibana